Literature DB >> 7781343

Cardiac hypertrophy in obstructive sleep apnea syndrome.

A Noda1, T Okada, F Yasuma, N Nakashima, M Yokota.   

Abstract

Fifty-one middle-aged male patients with obstructive sleep apnea syndrome (OSAS) were evaluated using two-dimensional echocardiography, 24-h blood pressure measurements, polysomnography, and plasma norepinephrine (NE) measurements. Among these patients, left ventricular hypertrophy (LVH) (left ventricular posterior wall thickness [LVPWT] or interventricular septal thickness [IVST] > or = 12 mm) and right ventricular hypertrophy (RVH) (right ventricular wall thickness [RVT] > or = 5 mm) were present in 41.2% (21/51) and 11.8% (6/51). LVH was present in 50.0% of group 2 patients (apnea index > or = 20) and in 30.5% of group 1 patients (apnea index < 20). All patients with LVH had hypertension. RVH was present in 21.4% of group 2 patients and none of the group 1 patients. IVST, LVPWT, LV mass, LV mass/body surface area (BSA), and obesity index were significantly greater in group 2 than in group 1. Apnea index and the duration in which nocturnal oxygen saturation was decreased under 90% (duration of SaO2 < 90%), were significantly correlated with LV mass/BSA and 24-h mean blood pressure. Apnea index, number of apneas, duration of nocturnal oxygen saturation less than 90%, weight, and obesity index were significantly greater in patients with both LVH and RVH than in patients without LVH and RVH, or those with only LVH. Plasma NE after waking significantly increased compared with that before sleep (p < 0.05). The ratio of plasma NE levels after waking to those before sleep was significantly correlated with the duration of SaO2 < 90% (r = 0.83, p < 0.05), but not with apnea index. These results suggest that frequent episodes of oxygen desaturation and/or arousal responses caused by apnea may contribute to the complication of LVH and RVH in the long term, and apnea-induced cyclical increases in blood pressure and the resulting sustained elevation in blood pressure associated with the increase in afterload and sympathetic activity may play a role in the development of LVH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781343     DOI: 10.1378/chest.107.6.1538

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  38 in total

1.  The effect of simulated obstructive apnoea on intraocular pressure and pulsatile ocular blood flow in healthy young adults.

Authors:  P O Lundmark; G E Trope; J G Flanagan
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle).

Authors:  Neal A Chatterjee; Ravi V Shah; Venkatesh L Murthy; Amy Praestgaard; Sanjiv J Shah; Corey E Ventetuolo; R Graham Barr; Richard Kronmal; Joao A C Lima; David A Bluemke; Michael Jerosch-Herold; Alvaro Alonso; Steven M Kawut
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-01

3.  Factors Contributing to Development and Reversal of LVH: A Pilot Study.

Authors:  Prasanna Kumar Hassan Ramaswamy; M Bhanukumar; Basavanagowdappa Hathur; K C Shashidhara; K M Srinath
Journal:  J Clin Diagn Res       Date:  2016-05-01

4.  Impact of continuous positive airway pressure treatment on myocardial performance in patients with obstructive sleep apnea. A conventional and tissue Doppler echocardiographic study.

Authors:  George Karamanzanis; Fotios Panou; George Lazaros; Evangelos Oikonomou; Ioannis Nikolopoulos; Makrina Mihaelidou; George Ntounis; John Lekakis
Journal:  Sleep Breath       Date:  2014-07-03       Impact factor: 2.816

5.  Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study.

Authors:  Hassan A Chami; Richard B Devereux; John S Gottdiener; Reena Mehra; Mary J Roman; Emelia J Benjamin; Daniel J Gottlieb
Journal:  Circulation       Date:  2008-05-05       Impact factor: 29.690

Review 6.  [Functional dynamics of the right ventricle and pulmonary circulation in obstructive sleep apnea. Therapeutic consequences].

Authors:  S Steiner; B E Strauer
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

Review 7.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

8.  Continuous positive airway pressure therapy reduces right ventricular volume in patients with obstructive sleep apnea: a cardiovascular magnetic resonance study.

Authors:  Ulysses J Magalang; Kathryn Richards; Beth McCarthy; Ahmed Fathala; Meena Khan; Narasimham Parinandi; Subha V Raman
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

9.  Association between QRS duration and obstructive sleep apnea.

Authors:  Shuchita Gupta; Beatriz Cepeda-Valery; Abel Romero-Corral; Abu Shamsuzzaman; Virend K Somers; Gregg S Pressman
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

10.  No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea.

Authors:  Izabela Grabska-Kobylecka; Andrzej Kobylecki; Piotr Bialasiewicz; Maciej Krol; Golsa Ehteshamirad; Marek Kasielski; Dariusz Nowak
Journal:  J Negat Results Biomed       Date:  2008-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.